The Relationship of Triglyceride/Glucose Index with Disease Severity, Sleep, and Cognitive Functions in Patients with Geriatric Depression: A Comparative Cross-Sectional Study with Healthy Controls


Donbaloğlu E. N., ÖZCAN H., Donbaloğlu M. A.

Clinical Gerontologist, 2026 (SCI-Expanded, SSCI, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1080/07317115.2026.2761064
  • Dergi Adı: Clinical Gerontologist
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus, Abstracts in Social Gerontology, AgeLine, CINAHL, EMBASE, MEDLINE, Psycinfo, Academic Search Ultimate (EBSCO), Health Research Premium Collection (ProQuest), Sociology Source Ultimate (EBSCO)
  • Anahtar Kelimeler: Cognitive functions, Geriatric depression, Insomnia, insulin resistance, Triglyceride/glucose index
  • Atatürk Üniversitesi Adresli: Evet

Özet

Objectives: This cross-sectional study investigated the association between the TyG index–a peripheral insulin resistance marker–and depression status, clinical severity, sleep quality, and cognitive functions in drug-naïve older adults compared to healthy controls. Methods: Older adults aged 60–74 (mean: 66.2 ± 3.8, range: 60–74; 65.5% depressed) comprising 76 patients with MDD and 40 controls were evaluated using GDS-15, ISI, and SMMSE. Assessor-blinded to the clinical psychiatric status of the participants. Results: The TyG index was significantly higher in patients than controls. Within the depressed cohort (n = 76), the TyG index correlated significantly with depression severity (r = 0.401, p <.001), but its cross-sectional associations with cognitive function (p =.110) and insomnia severity (p =.163) were non-significant. In multivariate logistic regression adjusted for age, sex, education, BMI, and comorbidities, the TyG index remained independently associated with higher odds of depression status (Exp(B)=24.935, p <.001). Exploratory ROC analysis revealed that a tentative cutoff of >8.78 discriminated depressed individuals with 63.16% sensitivity and 95.00% specificity (AUC = 0.804, p <.001). Conclusions: The TyG index is cross-sectionallyassociated with depression status and clinical severity in drug-naïveolder adults, independent of BMI. Clinical implications: The TyG index represents a cost-effective, noninvasive exploratory metabolic biomarker that may complement clinical screenings in late-life psychiatry.